Literature DB >> 26001331

Broadening the spectrum of SMARCB1-associated malignant tumors: a case of uterine leiomyosarcoma in a patient with schwannomatosis.

Irene Paganini1, Roberta Sestini1, Matilde Cacciatore2, Gabriele L Capone1, Luisa Candita1, Concetta Paolello3, Marta Sbaraglia2, Angelo P Dei Tos4, Sabrina Rossi2, Laura Papi1.   

Abstract

Schwannomatosis is a tumor predisposition syndrome characterized by development of multiple intracranial, spinal, and peripheral schwannomas. Constitutional alterations in either SMARCB1 or LZTR1 on 22q are responsible of the phenotype. We describe a 34-year-old woman who developed multiple benign peripheral sheath tumors and a uterine leiomyosarcoma. The patient carried a de novo constitutional alteration in exon 8 of SMARCB1, c.1118G > A, which destroyed the splice donor site of intron 8. Two schwannomas and the leiomyosarcoma of the patient retained the SMARCB1 mutation; in addition, the tumors showed loss of the normal chromosome 22. In conclusion, our findings enlarged the spectrum of SMARCB1-predisposing tumors and demonstrated, for the first time, the association of a malignant smooth muscle tumor to schwannomatosis. Therefore, clinicians should definitely be aware that a constitutional SMARCB1 mutation, which mainly predisposes to benign nerve sheath tumors, may also predispose to aggressive neoplasms throughout life, within an unexpected spectrum.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  LZTR1; Leiomyosarcoma; NF2; SMARCB1; Schwannomatosis

Mesh:

Substances:

Year:  2015        PMID: 26001331     DOI: 10.1016/j.humpath.2015.04.008

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

Review 1.  Germline variants in SMARCB1 and other members of the BAF chromatin-remodeling complex across human disease entities: a meta-analysis.

Authors:  Till Holsten; Susanne Bens; Florian Oyen; Karolina Nemes; Martin Hasselblatt; Uwe Kordes; Reiner Siebert; Michael C Frühwald; Reinhard Schneppenheim; Ulrich Schüller
Journal:  Eur J Hum Genet       Date:  2018-04-30       Impact factor: 4.246

2.  Malignant progression of a peripheral nerve sheath tumor in the setting of rhabdoid tumor predisposition syndrome.

Authors:  Santhosh A Upadhyaya; Rose B McGee; Breelyn A Wilky; Alberto Broniscer
Journal:  Pediatr Blood Cancer       Date:  2018-03-07       Impact factor: 3.167

3.  Multiple primary malignancies associated with a germline SMARCB1 pathogenic variant.

Authors:  Judith A Eelloo; Miriam J Smith; Naomi L Bowers; John Ealing; Paul Hulse; James P Wylie; Patrick Shenjere; Noel W Clarke; Calvin Soh; Richard W Whitehouse; Mark Jones; Christopher Duff; Anthony Freemont; D Gareth Evans
Journal:  Fam Cancer       Date:  2019-10       Impact factor: 2.375

Review 4.  The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.

Authors:  Hildegard Kehrer-Sawatzki; Said Farschtschi; Victor-Felix Mautner; David N Cooper
Journal:  Hum Genet       Date:  2016-12-05       Impact factor: 4.132

5.  ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis.

Authors:  D Gareth Evans; Stefania Mostaccioli; David Pang; Mary Fadzil O Connor; Melpo Pittara; Nicolas Champollion; Pierre Wolkenstein; Nick Thomas; Rosalie E Ferner; Michel Kalamarides; Matthieu Peyre; Laura Papi; Eric Legius; Juan Luis Becerra; Andrew King; Chris Duff; Stavros Stivaros; Ignacio Blanco
Journal:  Eur J Hum Genet       Date:  2022-04-01       Impact factor: 5.351

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.